• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结节性硬化症早期癫痫发作的治疗策略进展:综述与治疗方案

Evolving treatment strategies for early-life seizures in Tuberous Sclerosis Complex: A review and treatment algorithm.

作者信息

Samanta Debopam

机构信息

Division of Child Neurology, Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

出版信息

Epilepsy Behav. 2024 Dec;161:110123. doi: 10.1016/j.yebeh.2024.110123. Epub 2024 Nov 1.

DOI:10.1016/j.yebeh.2024.110123
PMID:39488094
Abstract

Tuberous sclerosis Complex (TSC) is a genetic disorder characterized by multisystem involvement, with epilepsy affecting 80-90% of patients, often beginning in infancy. Early-life seizures in TSC are associated with poor neurodevelopmental outcomes, underscoring the importance of timely and effective management. This review explores the evolving treatment landscape for TSC-associated seizures in young children, focusing on three recently approved or license-expanded therapies: vigabatrin, everolimus, and cannabidiol. The efficacy and safety profiles of these treatments are examined based on clinical trials and real-world evidence, with a focus on their use in treating seizures in young children. The preemptive use of vigabatrin in clinical studies has also been carefully reviewed. A treatment algorithm is proposed, emphasizing early diagnosis, prompt initiation of appropriate therapy, and a stepwise approach to managing both infantile spasms and focal seizures. The algorithm incorporates these newer therapies alongside traditional antiseizure medications and non-pharmacological approaches. Challenges in optimizing treatment strategies, minimizing side effects, and improving long-term outcomes are discussed. This review aims to guide clinicians in navigating the complex landscape of early-life seizures associated with TSC, ultimately striving for improved seizure control and better developmental outcomes in this vulnerable population.

摘要

结节性硬化症(TSC)是一种遗传性疾病,其特征为多系统受累,80-90%的患者会出现癫痫,且通常始于婴儿期。TSC患者的早期癫痫发作与不良的神经发育结局相关,这凸显了及时有效治疗的重要性。本综述探讨了幼儿TSC相关癫痫的不断演变的治疗格局,重点关注三种最近获批或扩大适应症的疗法:氨己烯酸、依维莫司和大麻二酚。基于临床试验和真实世界证据,对这些治疗方法的疗效和安全性进行了研究,重点关注它们在治疗幼儿癫痫发作中的应用。还仔细审查了氨己烯酸在临床研究中的预防性使用。提出了一种治疗算法,强调早期诊断、及时开始适当治疗以及逐步管理婴儿痉挛和局灶性癫痫发作的方法。该算法将这些新疗法与传统抗癫痫药物和非药物方法相结合。讨论了优化治疗策略、最小化副作用和改善长期结局方面的挑战。本综述旨在指导临床医生应对与TSC相关的早期癫痫发作的复杂局面,最终努力改善这一脆弱人群的癫痫控制和发育结局。

相似文献

1
Evolving treatment strategies for early-life seizures in Tuberous Sclerosis Complex: A review and treatment algorithm.结节性硬化症早期癫痫发作的治疗策略进展:综述与治疗方案
Epilepsy Behav. 2024 Dec;161:110123. doi: 10.1016/j.yebeh.2024.110123. Epub 2024 Nov 1.
2
Vigabatrin and mental retardation in tuberous sclerosis: infantile spasms versus focal seizures.氨己烯酸与结节性硬化症中的智力发育迟缓:婴儿痉挛症与局灶性癫痫发作
J Child Neurol. 2013 Mar;28(3):308-13. doi: 10.1177/0883073812446485. Epub 2012 Jun 29.
3
Pharmacotherapy for Seizures in Tuberous Sclerosis Complex.《结节性硬化症相关癫痫的药物治疗》
CNS Drugs. 2021 Sep;35(9):965-983. doi: 10.1007/s40263-021-00835-8. Epub 2021 Aug 21.
4
Vigabatrin for Epileptic Spasms and Tonic Seizures in Tuberous Sclerosis Complex.氨己烯酸用于结节性硬化症相关的癫痫性痉挛和强直发作
J Child Neurol. 2018 Jul;33(8):519-524. doi: 10.1177/0883073818768309. Epub 2018 Apr 24.
5
Vigabatrin for partial-onset seizure treatment in patients with tuberous sclerosis complex.氨己烯酸治疗结节性硬化症患者部分性发作。
Epilepsy Behav. 2013 Apr;27(1):118-20. doi: 10.1016/j.yebeh.2012.12.033. Epub 2013 Feb 11.
6
The Utility of Surveillance Electroencephalography to Guide Early Antiepileptic Drug Therapy in Infants With Tuberous Sclerosis Complex.监测脑电图在指导结节性硬化症婴儿早期抗癫痫药物治疗中的作用
Pediatr Neurol. 2017 Jul;72:76-80. doi: 10.1016/j.pediatrneurol.2017.04.009. Epub 2017 Apr 18.
7
Everolimus as adjunctive therapy for tuberous sclerosis complex-associated partial-onset seizures.依维莫司作为结节性硬化症相关部分性发作的辅助治疗。
Expert Rev Neurother. 2019 Oct;19(10):913-925. doi: 10.1080/14737175.2019.1635457. Epub 2019 Jul 23.
8
Epileptogenesis in tuberous sclerosis complex-related developmental and epileptic encephalopathy.结节性硬化症相关发育性和癫痫性脑病中的癫痫发生机制。
Brain. 2023 Jul 3;146(7):2694-2710. doi: 10.1093/brain/awad048.
9
Long-term efficacy and safety of cannabidiol in patients with tuberous sclerosis complex: 3-year results from the cannabidiol expanded access program.在结节性硬化症患者中使用大麻二酚的长期疗效和安全性:来自大麻二酚扩展使用项目的 3 年结果。
Epilepsia Open. 2024 Oct;9(5):1816-1825. doi: 10.1002/epi4.13013. Epub 2024 Aug 1.
10
Overview of therapeutic options for epilepsy.癫痫治疗选择概述。
Arch Pediatr. 2022 Dec;29(5S):5S14-5S19. doi: 10.1016/S0929-693X(22)00285-8.

引用本文的文献

1
Genetic screening of tuberous sclerosis complex in Sicily with a focus on neurological manifestations.西西里岛结节性硬化症的基因筛查:聚焦神经学表现
Sci Rep. 2025 Jun 27;15(1):20347. doi: 10.1038/s41598-025-04718-6.
2
Precision Therapeutics in Lennox-Gastaut Syndrome: Targeting Molecular Pathophysiology in a Developmental and Epileptic Encephalopathy.伦诺克斯-加斯托综合征的精准治疗:针对发育性和癫痫性脑病的分子病理生理学
Children (Basel). 2025 Apr 8;12(4):481. doi: 10.3390/children12040481.